Accrued Expenses and Other Liabilities

9 Months Ended

Jun. 30, 2011

Accrued Expenses and Other Liabilities [Abstract]

ACCRUED EXPENSES AND OTHER LIABILITIES

6. ACCRUED EXPENSES AND OTHER LIABILITIES

Accrued expenses and other liabilities are as follows:

	June 30,			September 30,
	2011			2010
				(audited)
Accrued royalties, rebates, chargebacks, and distribution fees	$	236,411		$	—
Accrued research and development expenses		261,256			221,956
Accrued selling, general and administrative expenses		1,711,462			537,347
Deferred rent		—			12,148
Other liabilities		140,000			—
Lease restructuring liability (1)		402,779			632,879
Total accrued expenses and other liabilities		2,751,908			1,404,330
Less: current portion		(2,607,241	)		(1,070,061	)
Non-current total accrued expenses and other liabilities	$	144,667		$	334,269

(1) In fiscal 2006, the Company relocated all operations other than research and development from San Diego, California to Aliso Viejo, California. In fiscal 2007, the Company subleased a total of approximately 49,000 square feet of laboratory and office space in San Diego and relocated remaining personnel and clinical trial support functions to the Company’s offices in Aliso Viejo, California. Restructuring expenses included recognition of the estimated loss due to the exit of the Company’s leases of approximately $2.1 million. No further costs were incurred related to these restructuring events in fiscal 2008. In April 2009, the Company entered into a sublease for office space in San Diego, California. Sublease rental payments commenced in September 2009 pursuant to this sublease.

     The following table presents the restructuring activities in fiscal 2011:

							Balance at
	Balance at						June 30,
	September 30, 2010			Payments/ Reductions			2011
	(audited)
Accrued Restructuring
Total lease restructuring liability	$	632,879		$	(230,100	)	$	402,779
Less current portion		(298,610	)					(278,112	)
Non-current portion	$	334,269					$	124,667